- stock
- bulk
Supplier Type
- Trader
- contract manufacturer
- custom synthesis
- Manufacturer
- Reagent
Supplier Region
- Maharashtra(44)
- New Delhi(7)
- Hyderabad(46)
- Pune(10)
- Gujarat(44)
- Beijing(4)
- Mumbai(94)
- Karnataka(11)
- Andhra Pradesh(5)
- Delhi(20)
- Ahmedabad(22)
- Tamil Nadu(2)
- Vadodara(15)
- Haryana(4)
- Punjab(1)
- Bangalore(2)
- Telangana(4)
- Uttar Pradesh(7)
- Madhya Pradesh(3)
- Kerela(1)
- Ujjain(1)
- Kolkata(4)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Purity By Gc Nlt 98%
- NLT 98%
- NLT 95%
- NLT 90.00%
- N/A
- More than 98%
- more than 95%
- MINIMUM 99%
- min 99%
- Min 98 %
- Mesalazine EP Impurity H
- Greater than 99%
- good
- Dipropargyl r- amino indane
- API Impurity / in-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.99
- 99.95%
- 99.90%
- >99.9%
- 99.9%
- 99.9 %
- 99.9
- 99.80 %
- 99.8%
- 99.6
- 99.5%+
- 99.5%
- 99.5 %
- 99.10%
- 99.00 %
- 99.0%
- 99%+
- 99%,HPLC
- 99% Minimum
- 99% Min
- 99% for GC
- 99% ABOVE
- > 99%
- >99%
- 99%
- 99 %
- 99
- 98=%
- 98+
- 98.5
- >98.0%
- 98.0%
- 98.0 %
- 98% Min.
- 98% min
- 98%
- >98%
- 98 % min
- 98 %
- 98 - 99 %
- 98
- 97-99%
- 97-99 %
- > 97.5 %
- 97.0%min,97%min
- 97% min
- 97%
- >97%
- 97 to 98
- > 96.5 %
- 96.5 - 103.5 %
- 96.14%
- 96% - 98%
- 96%
- 95-99%
- 95-98%
- 95%
- >95%
- 95
- 94%
- 92-95%
- >92%
- 90%-95%
- 90%
- 89%
- 85 percent Min
- 65%
- 600
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- 0.04%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0MG TO GRAM
- 100mg
- 250mg
- 1000mg
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1000g
- 1L
- ml
- 1kg
- 5kg
- 10kg
- 25kg
- 37kg
- 50kg
- 85kg
- 5020050 Kg Drum / 200 Kg Drum
- 77kg
- gms
- 100kg
- 103kg
- 124kg
- 127kg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 136kg
- 200kg
- 250kg
- 500kg
- 1000kg
- 1MT
- 5>
- 20ISO tank of MT
- 35Kgs
- 95NLT %
- 200Kg drum
- 200Kgs
- 500>
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 137kg
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
3''-Acetyl-2''-hydroxy-4-(4-phenylbutoxy)benzanilide
136450-06-1
-
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-
162012-67-1
-
N-Acetyl-L-cysteine
616-91-1
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
-
([1-Phenyl-meth-(E)-ylidene]-amino)-acetic acid ethyl ester
40682-54-0
-
LDAO
1643-20-5
-
N,N-Dimethylformamide
68-12-2
-
(IR,2S)-I-N,N-Diethylnorephedrine HCL
37025-59-5
-
N-Hydroxyphthalimide
524-38-9
N-[4-(2-Formylaminoacetyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide 149457-03-4
N-(3-Chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine 162012-67-1
N-Acetyl-L-cysteine 616-91-1
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
N,N-Dimethylformamide 68-12-2
(1R,2S)-I-N,N-Diethylnorephedrine Hydrochloride 37025-59-5
N-Hydroxyphthalimide 524-38-9
N-Bromosuccinimide 128-08-5
N-(2-Hydroxypropyl)Methacrylamide 21442-01-3
N-Cetyl-N,N,N-trimethylammonium chloride 112-02-7